Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for

We identified a total of 14 studies with a low or medium risk of bias for use in our main network meta-analyses (NWMA) comparing the efficacy of drug therapies for early rheumatoid arthritis. Those findings are presented in our main report.

Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis

Chapter 12 Network Meta-Analysis

Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples

Mapping the characteristics of network meta-analyses on drug therapy: A systematic review

A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate

A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials - The Lancet

Chapter 12 Network Meta-Analysis

Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysis - eClinicalMedicine

Chapter 10: Analysing data and undertaking meta-analyses

Meta-analysis and the science of research synthesis

Dismantling, optimising, and personalising internet cognitive behavioural therapy for depression: a systematic review and component network meta-analysis using individual participant data - The Lancet Psychiatry

A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania, Psychological Medicine

Meta-analysis - Wikipedia